or Try an Advanced Search...

    Technical Analysis for IOBT - IO Biotech, Inc.

    Grade Last Price % Change Price Change
    C 1.20 -3.23% -0.04
    IOBT closed down 3.23 percent on Friday, November 1, 2024, on 13 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical IOBT trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Shooting Star Candlestick Bearish -3.23%
    Stochastic Sell Signal Bearish -3.23%
    Lizard Bearish Bearish Day Trade Setup -3.23%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.23%
    Outside Day Range Expansion -3.23%
    Overbought Stochastic Strength -3.23%
    Older End-of-Day Signals for IOBT ...

       Recent Intraday Alerts

    Alert Time
    Fell Below 20 DMA about 21 hours ago
    20 DMA Support about 23 hours ago
    Down 3% about 23 hours ago
    Lizard Bearish Entry about 23 hours ago
    Shooting Star Candlestick Entry about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IOBT Chart by TradingView
    Basic chart:

    Profile

    IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death ligand (PD-L1). It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. IO Biotech, Inc. was incorporated in 2021 and is based in Copenhagen, Denmark.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Immune System Treatment Of Cancer Cancer Therapies Anti Cancer Therapies Urea Cycle

    Is IOBT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 4 IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
    Sep 18 Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
    Sep 16 Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
    Sep 14 IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer
    Sep 2 IO Biotech’s melanoma treatment trial to continue after IDMC review
    Aug 30 IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
    Aug 26 IO Biotech Announces Participation in Upcoming Investor Conferences
    Aug 13 IO Biotech GAAP EPS of -$0.31
    Aug 13 IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights
    Jul 25 IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024
    See more IOBT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.098
    52 Week Low 0.7327
    Average Volume 477,194
    200-Day Moving Average 1.40
    50-Day Moving Average 1.15
    20-Day Moving Average 1.19
    10-Day Moving Average 1.24
    Average True Range 0.10
    RSI (14) 50.74
    ADX 22.9
    +DI 25.88
    -DI 15.83
    Chandelier Exit (Long, 3 ATRs) 1.07
    Chandelier Exit (Short, 3 ATRs) 1.30
    Upper Bollinger Bands 1.34
    Lower Bollinger Band 1.04
    Percent B (%b) 0.52
    BandWidth 25.12
    MACD Line 0.04
    MACD Signal Line 0.03
    MACD Histogram 0.0034
    Fundamentals Value
    Market Cap 79.06 Million
    Num Shares 65.9 Million
    EPS -2.36
    Price-to-Earnings (P/E) Ratio -0.51
    Price-to-Sales 0.00
    Price-to-Book 0.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.34
    Resistance 3 (R3) 1.34 1.31 1.31
    Resistance 2 (R2) 1.31 1.27 1.30 1.30
    Resistance 1 (R1) 1.25 1.25 1.24 1.25 1.30
    Pivot Point 1.22 1.22 1.21 1.21 1.22
    Support 1 (S1) 1.16 1.18 1.15 1.16 1.10
    Support 2 (S2) 1.13 1.16 1.12 1.10
    Support 3 (S3) 1.07 1.13 1.09
    Support 4 (S4) 1.07